BIOMAT Database Logo BIOMAT Database Logo

The Measles Control Campaign and immunisation adverse events. 1998

M A Burgess, and T C Heath, and P B McIntyre

UI MeSH Term Description Entries
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D009108 Mumps Vaccine Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine. Inactivated Mumps Vaccine,Inactivated Mumps Virus Vaccine,Live Attenuated Mumps Vaccine,Live Attenuated Mumps Virus Vaccine,Mumps Vaccine, Inactivated,Mumps Vaccine, Live Attenuated,Mumps Virus Vaccine, Inactivated,Mumps Virus Vaccine, Live Attenuated,Vaccine, Inactivated Mumps,Vaccine, Mumps
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001315 Australia The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra. Canton and Enderbury Islands,Christmas Island,Christmas Island (Australia)

Related Publications

M A Burgess, and T C Heath, and P B McIntyre
Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
February 2000, Communicable diseases intelligence,
M A Burgess, and T C Heath, and P B McIntyre
National measles and rubella immunisation campaign.
August 1994, Communicable disease report. CDR weekly,
M A Burgess, and T C Heath, and P B McIntyre
The measles/rubella immunisation campaign in Scotland.
January 1996, Health bulletin,
M A Burgess, and T C Heath, and P B McIntyre
Measles and rubella immunisation campaign. Safety untested.
October 1994, BMJ (Clinical research ed.),
M A Burgess, and T C Heath, and P B McIntyre
Evaluating the measles immunisation campaign. Evidence on measles is unreliable.
July 1995, BMJ (Clinical research ed.),
M A Burgess, and T C Heath, and P B McIntyre
Adverse reactions to measles immunisation.
September 1994, BMJ (Clinical research ed.),
M A Burgess, and T C Heath, and P B McIntyre
Immunisation adverse events clinics.
January 2003, New South Wales public health bulletin,
M A Burgess, and T C Heath, and P B McIntyre
Adverse events associated with Measles and Rubella vaccination campaign 2019 in India.
January 2021, Clinical and experimental vaccine research,
M A Burgess, and T C Heath, and P B McIntyre
Unsustainability of a measles immunisation campaign--rise in measles incidence within 2 years of the campaign.
May 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M A Burgess, and T C Heath, and P B McIntyre
Appropriate season for measles immunisation campaign in India.
September 1995, The Journal of communicable diseases,
Copied contents to your clipboard!